MA

MAXCYTE, INC.

  • CIK: 0001287098
  • EIN: 52-2210438
  • Business address: 22 FIRSTFIELD ROAD, SUITE 250, GAITHERSBURG, Maryland, 20878

Information

  • Mailing address
    22 FIRSTFIELD ROAD, SUITE 250, GAITHERSBURG, Delaware, 20878
  • Phone
    301-517-5556
  • State location
    Maryland
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
  • Filings
    N/A

About MAXCYTE, INC.

MAXCYTE, INC. (CIK: 0001287098) is an American company incorporated in the state of Maryland. Head office is located at 22 FIRSTFIELD ROAD, SUITE 250, GAITHERSBURG, Maryland, 20878. Work in the industry 8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH. MAXCYTE, INC. is a public company and trade via Over-The-Counter (OTC).

Old names:

  • MAXCYTE INC from 2004-14-Apr to 2008-18-Sep

Ownership

Owner Filings Transaction Date Type of Owner
BALTHROP PATRICK J 0001284839 Nov-30-2022 director
Sumen Cenk 0001917133 Mar-07-2022 officer: Chief Scientific Officer
DOUGLAS RICHARD 0001021015 Jul-29-2021 director
THOMPSON J STARK PHD 0001241146 Jul-29-2021 director
Erck Stanley C 0001342826 Jul-29-2021 director
Casdin Partners GP, LLC 0001534260 Jul-29-2021 10 percent owner
Casdin Capital, LLC 0001534261 Jul-29-2021 10 percent owner
Casdin Eli 0001534264 Jul-29-2021 10 percent owner
Casdin Partners Master Fund, L.P. 0001534265 Jul-29-2021 10 percent owner
Brooke William W 0001545337 Jul-29-2021 director
Al-Wakeel Yasir B. 0001650691 Jul-29-2021 director
Hemrajani Rekha 0001771213 Jul-29-2021 director
Doerfler Douglas 0001874482 Jul-29-2021 director, officer: President and CEO
Holtz Ron 0001874490 Jul-29-2021 officer: SVP and CAO
Mandell Art 0001874506 Jul-29-2021 director
Masoud Maher 0001874571 Jul-29-2021 officer: EVP and General Counsel
Ross Thomas M. 0001874572 Jul-29-2021 officer: EVP, Global Sales
Johnston John Joseph 0001874850 Jul-29-2021 director
Murphy Amanda Louise 0001875169 Jul-29-2021 officer: Chief Financial Officer

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by MAXCYTE, INC.

Filings Format Description Filed/Effective File/Film Number
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001104659-26-095971 (34 Act) Size: KB		 Aug-13-2026

001-40674

261274128
8-K Document

Current report filing

Acc-no: 0001104659-26-094886 (34 Act) Size: KB		 Aug-12-2026

001-40674

261267647
SCHEDULE 13D Document Acc-no: 0001486180-26-000003 (34 Act) Size: KB Aug-04-2026

005-92738

261235674
SCHEDULE 13G/A Document Acc-no: 0002012383-26-002825 (34 Act) Size: KB Jul-29-2026

005-92738

261216862
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-26-003056 ( Act) Size: 0 KB		 Jun-22-2026

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-26-003055 ( Act) Size: 0 KB		 Jun-22-2026

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-26-003054 ( Act) Size: 0 KB		 Jun-22-2026

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-26-003053 ( Act) Size: 0 KB		 Jun-22-2026

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-26-003052 ( Act) Size: 0 KB		 Jun-22-2026

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-26-003051 ( Act) Size: 0 KB		 Jun-22-2026

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-26-003050 ( Act) Size: 0 KB		 Jun-22-2026

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-26-003049 ( Act) Size: 0 KB		 Jun-22-2026

8-K Document

Current report filing

Acc-no: 0001104659-26-075211 (34 Act) Size: KB		 Jun-17-2026

001-40674

261099315
8-K Document

Current report filing

Acc-no: 0001104659-26-074594 (34 Act) Size: KB		 Jun-16-2026

001-40674

261094923
SCHEDULE 13D Document Acc-no: 0001486180-26-000002 (34 Act) Size: KB May-14-2026

005-92738

26976257
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001104659-26-060290 (34 Act) Size: KB		 May-13-2026

001-40674

26973941
8-K Document

Current report filing

Acc-no: 0001104659-26-059399 (34 Act) Size: KB		 May-12-2026

001-40674

26968672
ARS Document

Annual report to security holders

Acc-no: 0001140361-26-017847 (34 Act) Size: KB		 Apr-29-2026

001-40674

26917335
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0001140361-26-017845 (34 Act) Size: KB		 Apr-29-2026

001-40674

26917311
DEF 14A Document

Definitive proxy statements

Acc-no: 0001140361-26-017844 (34 Act) Size: KB		 Apr-29-2026

001-40674

26917280

Recent 20 filings. View all MAXCYTE, INC. filings

Reviews

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Frequently Asked Questions

Tags:

  • MAXCYTE, INC. overview
  • MAXCYTE, INC. job
  • MAXCYTE, INC. stock
  • MAXCYTE, INC. ownership
  • MAXCYTE, INC. CEO
  • MAXCYTE, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

OTSAW Ltd
Update: Jun 10, 2025
Zymergen Inc.
Update: Aug 26, 2022
XXSYS TECHNOLOGIES INC /CA
Update: Aug 25, 2022
WHISTLER INC
Update: Aug 25, 2022
WCG Clinical, Inc.
Update: Aug 25, 2022
Viventia Biotech Inc.
Update: Aug 24, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2609 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 1614 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4386 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 3262 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 1170 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2517 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 1905 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 2170 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 4749 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by